Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 21, 2014
Clinical News
ImStem Biotechnology preclinical data
...and funding for Phase I trials of hES-MSCs but could not be reached for details.
ImStem Biotechnology Inc.
...
Read More
BioCentury
|
Sep 2, 2013
Financial News
ImStem Biotechnology completes venture financing
ImStem Biotechnology Inc.
, Farmington, Conn. Business: Gene/Cell therapy, Cardiovascular, Autoimmune Date completed: 8/20/13 Type: Venture financing Raised: $75,000 Investors: Connecticut Innovations Note: ImStem received $75,000 of an expected $150,000 financing. WIR Staff...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jul 21, 2014
Clinical News
ImStem Biotechnology preclinical data
...and funding for Phase I trials of hES-MSCs but could not be reached for details.
ImStem Biotechnology Inc.
...
Read More
BioCentury
|
Sep 2, 2013
Financial News
ImStem Biotechnology completes venture financing
ImStem Biotechnology Inc.
, Farmington, Conn. Business: Gene/Cell therapy, Cardiovascular, Autoimmune Date completed: 8/20/13 Type: Venture financing Raised: $75,000 Investors: Connecticut Innovations Note: ImStem received $75,000 of an expected $150,000 financing. WIR Staff...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page